Albania vs Turkmenistan: Cause of death, by non-communicable diseases, female
Albania
74.8%
in 2021
Turkmenistan
74.0%
in 2021
Albania rank
66th
Turkmenistan rank
69th
Cause of death, by non-communicable diseases, female over time
- Albania
- Turkmenistan
How they compare
Albania currently reports 74.8% against 74.0% in Turkmenistan, a difference of 0.8%.
Across all 6 years both countries report, Albania has been ahead every year.
Albania ranks 66th and Turkmenistan ranks 69th of 185 countries.
Albania has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Albania | Turkmenistan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 87.5% | 70.7% | 16.8% | Albania |
| 2010s | 93.9% | 75.1% | 18.8% | Albania |
| 2020s | 80.9% | 72.8% | 8.1% | Albania |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, female, Albania or Turkmenistan?
- Albania, at 74.8% against 74.0% in Turkmenistan as of 2021.
- What is the difference in cause of death, by non-communicable diseases, female between Albania and Turkmenistan?
- 0.8%, with Albania ahead.
- How many years of comparable data are there for Albania and Turkmenistan?
- 6 years are reported by both, from 2000 to 2021.
- How do Albania and Turkmenistan rank globally for cause of death, by non-communicable diseases, female?
- Albania ranks 66th and Turkmenistan ranks 69th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, female (% of total female deaths). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths due to non-communicable diseases divided by number of all female deaths, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.